Plasma exchange and intravenous immunoglobulin in the treatment of antibody-mediated rejection after kidney transplantation: a single-center historic cohort study.

@article{Gubensek2013PlasmaEA,
  title={Plasma exchange and intravenous immunoglobulin in the treatment of antibody-mediated rejection after kidney transplantation: a single-center historic cohort study.},
  author={Jakob Gubensek and Jadranka Buturovic-Ponikvar and Aljo{\vs}a Kandus and Miha Arnol and Janko Kova{\vc} and Andreja Marn-Pernat and Jelka Lindi{\vc} and Damjan Kovac and Rafael Ponikvar},
  journal={Transplantation proceedings},
  year={2013},
  volume={45 4},
  pages={1524-7}
}
BACKGROUND Antibody-mediated rejection (AMR) of a kidney graft has been increasingly recognized as an important cause of graft failure. Our historic cohort study sought to analyze its treatment and outcomes at our center. METHODS All patients with AMR between 2005 and 2011 were treated with plasma exchange (PE), intravenous low-dose cytomegalovirus (CMV) hyperimmune globulin, and adjustment of basal immunosuppression. We analyzed data regarding baseline characteristics, rejection treatment… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-8 of 8 extracted citations

Therapy Modalities for Antibody Mediated Rejection in Renal Transplant Patients.

Journal of investigative surgery : the official journal of the Academy of Surgical Research • 2016
View 6 Excerpts
Highly Influenced

Late antibody-mediated rejection after heart transplantation: Mortality, graft function, and fulminant cardiac allograft vasculopathy.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation • 2015

Early donor-specific antibodies in lung transplantation: risk factors and impact on survival.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation • 2014
View 2 Excerpts

Similar Papers

Loading similar papers…